SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently trending as investors weigh significant long-term investments in custom AI chips and infrastructure against short-term concerns over model development delays and broader geopolitical instability. The community remains deeply divided, with many retail traders actively buying the dip, while others express frustration over the stock's recent volatility and sensitivity to macro headwinds.

Trump For President

TRUMP is trending as investors react to a speculative Mar-a-Lago event invite for top holders, sparking intense debate across social media regarding potential market manipulation and the token's long-term viability. While bulls highlight the potential for high volatility and speculative upside, critics are vocally expressing concerns about the project's association with political grifting and the broader instability of meme-driven assets.

TOSHI

TOSHI is seeing increased community activity as participants speculate on a potential breakout, focusing on technical setups and its role within the Base ecosystem. Investors are actively discussing accumulation strategies and potential catalysts, while maintaining a bullish long-term outlook despite broader market volatility.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is currently trending as investors weigh a major $13 billion U.S. investment plan aimed at revitalizing domestic manufacturing and job creation against broader industry headwinds. While the community is actively debating the stock's long-term valuation and turnaround potential, sentiment remains split between those betting on an undervalued cyclic recovery and those expressing skepticism over management's execution and ongoing supply chain challenges.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors react to a strategic contract win with L3Harris to support the Space Development Agency's tracking layer, while the community remains hyper-focused on the anticipated Lunar Terrain Vehicle (LTV) contract announcement. Traders are actively debating the stock's volatility and its potential to break out of recent price ranges as the company approaches its upcoming earnings release.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is garnering market attention as investors weigh the stock's potential for a rebound driven by anticipated interest rate cuts against concerns over low real estate transaction volumes and ongoing litigation risks. Community discussion remains polarized, with some focusing on long-term bullish sentiment tied to the company's leading market share and integration of new AI search capabilities, while others remain skeptical due to prevailing industry headwinds.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is attracting significant attention as a core infrastructure play, with community members highlighting its role in the real-world asset (RWA) sector and its integration into institutional-grade data feeds. Discussions are currently centered on the network's token buyback program, growing decentralized finance adoption, and its positioning as a high-utility alternative to speculative meme coins.

Volatility Shares Trust - 2x Ether ETF

Volatility Shares 2x Ether ETF

The Volatility Shares 2x Ether ETF (ETHU) is trending as traders attempt to capitalize on heightened Ethereum volatility, with the community actively debating the risks of leverage decay versus the potential for outsized gains during crypto breakouts. Market participants are intensely focused on ETHUs performance relative to underlying Ethereum price movements, with many viewing it as a high-risk momentum vehicle for short-term day trading rather than a long-term hold.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting significant retail attention as investors debate the commercial traction of its flagship fibromyalgia drug, Tonmya, against persistent concerns over share dilution and the company's historical financial performance. While some community members are optimistic about accelerating prescription trends and recent formulary coverage, others are actively shorting the stock, citing ongoing cash burn and skepticism toward management's long-term execution.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's (PTLO) is currently a focal point for investors debating a potential turnaround, driven by a recent surge in high-volume traffic at new location openings and persistent speculation regarding insider accumulation and undervalued assets. While sentiment remains divided between those betting on long-term growth and others wary of margin pressures and leadership transitions, the community is actively tracking regional expansion performance as a key indicator of future stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Barclays Issues Positive Forecast for Oruka Therapeutics (NASDAQ:ORKA) Stock Price

Barclays raised their price objective on Oruka Therapeutics from $48.00 to $50.00 and gave the company an "overweight" rating in a research note on Friday...

Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $72.00

Stifel Nicolaus boosted their target price on shares of Oruka Therapeutics from $47.00 to $72.00 and gave the stock a "buy" rating in a research report on Friday...

Oruka Therapeutics (NASDAQ:ORKA) Given "Buy" Rating at BTIG Research

BTIG Research restated a "buy" rating and set a $73.00 price objective on shares of Oruka Therapeutics in a report on Friday...

Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week High on Strong Earnings

Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High on Better-Than-Expected Earnings...

Oruka Therapeutics (NASDAQ:ORKA) Receives "Outperform" Rating from Wedbush

Wedbush reaffirmed an "outperform" rating and issued a $45.00 price objective on shares of Oruka Therapeutics in a research report on Friday...

Oruka Therapeutics (NASDAQ:ORKA) Earns "Buy" Rating from Guggenheim

Guggenheim reiterated a "buy" rating and issued a $60.00 price target on shares of Oruka Therapeutics in a report on Friday...

Oruka Therapeutics (NASDAQ:ORKA) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS

Oruka Therapeutics (NASDAQ:ORKA - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts...

Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 7.8% - Time to Sell?

Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 7.8% - Should You Sell...

Oruka Therapeutics (NASDAQ:ORKA) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered shares of Oruka Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 17.2% in February

Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) saw a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 4,062,540...

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

ORKA
Oruka Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ORKA News

ORKAOruka Therapeutics Inc.